Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome?

We describe a family with four members, a mother, two sons, and a daughter, who show clinical features consistent with X linked Alport syndrome. The two males presented with additional features including mental retardation, dysmorphic facies with marked midface hypoplasia, and elliptocytosis. The elliptocytosis was not associated with any detectable abnormalities in red cell membrane proteins; red cell membrane stability and rigidity was normal on ektacytometry. Molecular characterisation suggests a submicroscopic X chromosome deletion encompassing the entire COL4A5 gene. We propose that the additional abnormalities found in the affected males of this family are attributable to deletion or disruption of X linked recessive genes adjacent to the COL4A5 gene and that this constellation of findings may represent a new X linked contiguous gene deletion syndrome.

[1]  A. Michael,et al.  Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. , 1986, The Journal of clinical investigation.

[2]  A. Ballabio,et al.  Deletion spanning the 5′ ends of both the COL4A5 and COL4A6 genes in a patient with Alport's syndrome and leiomyomatosis , 1994, Human mutation.

[3]  D. Barker,et al.  Two CA-dinucleotide polymorphisms at the COL4A5 (Alport syndrome) gene in Xq22. , 1992, Nucleic acids research.

[4]  K. Tryggvason,et al.  Complete amino acid sequence of the human alpha 5 (IV) collagen chain and identification of a single-base mutation in exon 23 converting glycine 521 in the collagenous domain to cysteine in an Alport syndrome patient. , 1992, The Journal of biological chemistry.

[5]  C. Guyot,et al.  Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours , 1995 .

[6]  Y. Sado,et al.  Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. , 1994, The American journal of pathology.

[7]  R. Butkowski,et al.  Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. , 1989, Kidney international.

[8]  M. Skolnick,et al.  Identification of mutations in the COL4A5 collagen gene in Alport syndrome. , 1990, Science.

[9]  A. Donnelly,et al.  How many X-linked genes for non-specific mental retardation (MRX) are there? , 1996, American journal of medical genetics.

[10]  A. Ballabio,et al.  X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. , 1996, American journal of human genetics.

[11]  C. Epstein,et al.  Hereditary macrothrombocytopathia, nephritis and deafness. , 1972, The American journal of medicine.

[12]  J. Gitschier,et al.  The gene encoding the palmitoylated erythrocyte membrane protein, p55, originates at the CpG island 3' to the factor VIII gene. , 1992, Human molecular genetics.

[13]  N. Mohandas,et al.  Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. , 1995, The Journal of clinical investigation.

[14]  C. Antignac,et al.  Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. , 1996, American journal of human genetics.

[15]  P. Bryant,et al.  A major palmitoylated membrane protein of human erythrocytes shows homology to yeast guanylate kinase and to the product of a Drosophila tumor suppressor gene , 1992, Cell.

[16]  M. Telen,et al.  Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype. , 1991, Blood.

[17]  D. Speicher,et al.  Molecular identification of a major palmitoylated erythrocyte membrane protein containing the src homology 3 motif. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Chompret,et al.  Genetic heterogeneity of Alport syndrome. , 1985, Kidney international.

[19]  C. Gazengel,et al.  Hereditary nephritis associated with May-Hegglin anomaly. , 1981, Nephron.

[20]  H. Smeets,et al.  Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. , 1994, Nature genetics.

[21]  C. Antignac,et al.  Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. , 1994, The Journal of clinical investigation.

[22]  M. Pembrey,et al.  Multiple pterygium syndrome: evolution of the phenotype. , 1987, Journal of Medical Genetics.

[23]  K. Dahan,et al.  Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females. , 1995, Kidney international.

[24]  D. Sheer,et al.  Molecular cloning of alpha 5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. , 1990, American journal of human genetics.

[25]  C. Guyot,et al.  Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. , 1995, Human molecular genetics.

[26]  N. Mohandas,et al.  A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders. , 1982, Blood.

[27]  M. Reid,et al.  Effects of deficiencies of glycophorins C and D on the physical properties of the red cell , 1990, British journal of haematology.

[28]  V. Marchesi,et al.  Abnormal spectrin in hereditary elliptocytosis. , 1986, Blood.

[29]  A. Ballabio,et al.  Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. , 1995, American journal of medical genetics.

[30]  A. Michael,et al.  A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen. , 1994, Kidney international.

[31]  A. Michael,et al.  Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[32]  H. Smeets,et al.  Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. , 1993, Science.

[33]  J. White,et al.  Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. , 1985, Blood.

[34]  A. Chishti,et al.  Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. , 1993, Blood.

[35]  S. Weed,et al.  Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia. , 1997, The Journal of clinical investigation.

[36]  Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. , 1993, Blood.